INSTAGE data for nintedanib in advanced IPF published

Clinical trial data for nintedanib in patients with advanced IPF published   INSTAGE ® trial results published in the New England Journal of Medicine1Trial provides clinical data on patients with IPF and severe impairment in gas exchange usually excluded from clinical trials1Efficacy and safety profile of nintedanib in patients with advanced IPF was consistent with that observed in patients with less advanced disease in earlier trials1,2,3,4Sildenafil plus nintedanib did not provide significant benefit   versus nintedanib alone1 
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news